New Diagnostic Technology May Lead to Individualized Treatments for Prostate Cancer, Cedars-Sinai Medical Center and University of California, Los Angeles (UCLA) Study

Published: Apr 02, 2013

A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.

Back to news